文献速递肥胖与代谢综合征

代谢综合征与肾结石风险:来自487 860名英国生物银行参与者的证据

Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

基于英国生物银行487 860名基线无肾结石参与者的前瞻性队列数据进行的回顾性分析,平均随访12.6年,共5213人发生肾结石。腰围、HDL胆固醇、高血压和2型糖尿病等代谢综合征部分特征与肾结石独立相关,代谢综合征特征聚集与肾结石形成显著相关,且随特征数量增加风险逐渐升高。

要点

  • 腰围(HR 1.15)、HDL胆固醇(HR 0.66)、高血压(HR 1.11)和2型糖尿病(HR 1.14)与肾结石独立相关。
  • 代谢综合征特征聚集与肾结石形成显著相关,特征数量越多肾结石风险逐渐升高。
  • 代谢综合征是肾结石发生的显著独立危险因素。

核心结论

  • 代谢综合征是肾结石发生的显著且独立的危险因素。
  • 该关联提示肾结石可能代表一种受多种代谢危险因素相互作用影响的系统性疾病。

研究设计与样本

  • 对英国生物银行487 860名基线无肾结石参与者的前瞻性队列数据进行回顾性分析。
  • 代谢综合征依据5项标准判定:腹型肥胖、高甘油三酯、低高密度脂蛋白胆固醇、高血压和2型糖尿病。
  • 采用Cox比例风险回归模型评估代谢综合征与肾结石风险的关联。

主要发现

  • 平均随访12.6年后,487 860名参与者中共5213人发生肾结石。
  • 腰围(HR 1.15;95%CI 1.10-1.20)与肾结石发生独立相关。
  • HDL胆固醇(HR 0.66;95%CI 0.55-0.79)与肾结石发生独立相关。
  • 高血压(HR 1.11;95%CI 1.03-1.19)与肾结石发生独立相关。
  • 2型糖尿病(HR 1.14;95%CI 1.04-1.21)与肾结石发生独立相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: While some studies have suggested an association between metabolic syndrome and kidney stones, the quality and level of evidence in these studies vary. OBJECTIVE: Whether some individual characteristics and clustering of metabolic syndrome traits increase the risk of kidney stones has not been examined in a large-scale prospective cohort. MATERIALS: We conducted a retrospective analysis of data from a prospective cohort of 487 860 UK Biobank participants who were free from kidney stones at baseline. The presence of metabolic syndrome was based on 5 criteria: abdominal obesity, high triglyceride levels, low high-density lipoprotein (HDL) cholesterol levels, high blood pressure (HBP), and type 2 diabetes mellitus (T2DM). Cox proportional hazards regression models were used to evaluate the association between metabolic syndrome and risk of kidney stones. RESULTS: After an average follow-up period of 12.6 years, a total of 5213 of the 487 860 participants included in the UK Biobank study developed kidney stones. The partial traits of metabolic syndrome, including waist circumference (hazard ratio [HR]: 1.15; 95% CI, 1.10-1.20), HDL cholesterol (0.66; 95% CI, 0.55-0.79), HBP (1.11; 95% CI, 1.03-1.19), and T2DM (1.14; 95% CI, 1.04-1.21), were independently associated with the occurrence of kidney stones. The clustering of metabolic syndrome is significantly associated with kidney stone formation, and as the number of metabolic syndrome traits increases, the risk of kidney stones gradually increases. CONCLUSION: Metabolic syndrome is a significant and independent risk factor for the development of kidney stones. This association suggests that kidney stones may represent a systemic disorder influenced by the interplay of various metabolic risk factors.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Liu M, Gao M, Wu J, et al. Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants. J Clin Endocrinol Metab. 2025. PMID: 38701346. doi:10.1210/clinem/dgae295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。